Search results
Author(s):
Eleftherios Giazitzoglou
Added:
3 years ago
Dear Sir,
I read with great interest the comprehensive review of Dr Brugada and Dr Keegan on asymptomatic pre-excitation, and the issues of risk stratification and need for catheter ablation.1 Perhaps the authors would like to comment on two additional studies that have just appeared, but contain vital information for the appropriate management of these patients. The first study emanates from a…
View more
Author(s):
Josep Brugada
,
Roberto Keegan
Added:
3 years ago
Dear Sir,
We appreciate the interest of Dr Eleftherios Giozitzoglou in our work.1 In the first retrospective registry,2 in which more than 300,000 individuals had an ECG over a period of 11 years (29 % of total population), a separate analysis of asymptomatic subjects and sudden cardiac death was not addressed in the group of 310 subjects with ventricular pre-excitation. However, and…
View more
Author(s):
Juan Sieira
,
Pedro Brugada
Added:
3 years ago
Brugada syndrome (BS) is an inherited disease characterised by coved-type ST-segment elevation in the right precordial leads (V1–V3) and an increased risk of sudden cardiac death (SCD) in the absence of structural heart disease.1
It typically affects otherwise healthy individuals in their forties.2 SCD is the most dramatic presentation, but many patients are asymptomatic at the time of diagnosis…
View more
Author(s):
Josep Brugada
,
Roberto Keegan
Added:
3 years ago
The best clinical approach to managing asymptomatic patients with ventricular pre-excitation has yet to be established. The clinical benefit of identifying and treating asymptomatic patients at risk of sudden cardiac death (SCD) has been debated since catheter ablation became effective and safe for the treatment of accessory pathways (APs). Data supporting current recommendations are mostly…
View more
Author(s):
A John Camm
Added:
3 years ago
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2 % of the general population and is increasingly prevalent in older people, occurring in about 10 % of over 80 year olds.1 AF is associated with a variety of cardiovascular conditions. The arrhythmia is associated with a five-fold rise in stroke risk and frequently coexists with heart failure, both leading…
View more
Author(s):
Vincent Probst
,
Stéphanie Chatel
,
Jean-Baptiste Gourraud
,
et al
Added:
3 years ago
Brugada syndrome (BrS) is a clinical entity identified in 1992 by Brugada brothers from a file of patients resuscitated from sudden cardiac death (SCD).1 Of these patients, some had a specific electrocardiogram (ECG) appearance characterised by an incomplete right bundle branch block associated with an ST segment elevation in the right precordial leads. It quickly became apparent that this…
View more
Author(s):
Thorsten Lewalter
,
Giuseppe Boriani
Added:
3 years ago
The monitoring of atrial fibrillation (AF) can be performed using a great variety of strategies and tools. Strategies range from monitoring only symptomatic AF (e.g., post-catheter ablation with or without surface electrocardiogram [ECG] documentation) to continuously monitoring heart rhythm using implantable pacemakers, implantable cardioverter defibrillators (ICDs) or subcutaneous implantable…
View more
Author(s):
Gerhard Hindricks
,
Faizel Osman
,
Keitaro Senoo
,
et al
Added:
4 months ago
This video series page covers content associated with Atrial Fibrillation.AFib is associated with a 5x greater risk of stroke, however with effective treatment, the risk of stroke can be reduced.¹ The lifetime risk for AFib is 1 in 3 individuals² and it often occurs with hypertension. Early detection is key, to allow for prompt and satisfactory disease management to not only control symptoms but…
View more
Author(s):
Carlo Pappone
,
Vincenzo Santinelli
Added:
3 years ago
Historical Precedents
Brugada syndrome (BrS) was first described more than 25 years ago as a clinical entity in people resuscitated from sudden cardiac death due to documented VF.1 The original 1992 case series described eight patients without apparent structural heart disease who all had VF associated with persistent coved ST-segment elevation in the right precordial leads.1 In 1996 this…
View more
Author(s):
Oholi Tovia-Brodie
,
Yoav Michowitz
,
Bernard Belhassen
Added:
3 years ago
Brugada syndrome (BrS) is a cardiac disease caused by an inherited ion channelopathy. It was first described by the Brugada brothers in 19921 and is associated with a propensity to develop ventricular fibrillation (VF). Brugada syndrome is characterised by prominent J waves appearing as an ST segment elevation in the right precordial leads. In the latest guidelines, diagnosis of BrS constitutes…
View more